Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$119.77M
Total Bought:
$24.50M
Total Sold:
$57.10M
Net Transaction:
-$32.61M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Verastem, Inc.(VSTM)3,349,6273,042,775-306,852$12.80M$24.49M20.45%+$11.70M
CAMP4 THERAPEUTICS CORPORATION(CAMP)1,389,6222,786,249+1,396,627$6.07M$11.26M9.40%+$5.18M
Evolus, Inc.(EOLS)1,590,162971,622-618,540$11.04M$7.77M6.49%-$3.26M
Adma Biologics Inc740,000700,000-40,000$6.19M$7.02M5.86%+$827.2K
Nektar Therapeutics(NKTR)120,654110,000-10,654$8.42M$6.66M5.56%-$1.76M
Eloxx Pharmaceuticals Inc397,160381,977-15,183$5.51M$5.85M4.88%+$335.5K
Satellos Bioscience Inc.(MSLE)491,624455,058-36,566$3.72M$3.87M3.23%+$143.0K
Kazia Therapeutics LimitedADS(KZIA)345,179377,429+32,250$4.86M$3.62M3.02%-$1.24M
Indivior Pharmaceuticals Inc(INDV)100,000100,0000$4.10M$3.58M2.99%-$518.0K
Ultragenyx Pharmaceutical Inc.(RARE)25,000210,000+185,000$834.8K$3.16M2.64%+$2.32M
Edesa Biotech, Inc.(EDSA)456,439710,266+253,827$3.19M$2.99M2.50%-$200.6K
Boston Scientific Corporation(BSX)055,000+55,000$0$2.40M2.00%+$2.40M
Aytu Biopharma Inc912,921964,900+51,979$1.96M$2.06M1.72%+$102.1K
An2 Therapeutics Inc551,692350,877-200,815$2.67M$1.87M1.56%-$803.5K
Xilio Therapeutics, Inc.(XLO)225,994189,092-36,902$2.17M$1.71M1.43%-$453.7K
Pyxis Oncology, Inc.(PYXS)0689,000+689,000$0$1.61M1.34%+$1.61M
Abeona Therapeutics Inc.(ABEO)557,284282,016-275,268$3.44M$1.48M1.24%-$1.96M
Surrozen, Inc.(SRZN)044,100+44,100$0$1.42M1.18%+$1.42M
Cellectar Biosciences, Inc.(CLRB)104,550749,028+644,478$290.6K$1.38M1.15%+$1.09M
Pasithea Therapeutics Corp.(KTTA)2,201,4682,774,234+572,766$1.13M$1.37M1.14%+$233.1K
Adicet Bio Inc245,518188,201-57,317$2.12M$1.34M1.12%-$777.5K
Inhibikase Therapeutics, Inc.(IKT)396,179647,285+251,106$804.2K$1.33M1.11%+$525.9K
OKYO Pharma LimitedSHS NEW(OKYO)862,996914,367+51,371$1.29M$1.18M0.98%-$115.0K
Quoin Pharmaceuticals, Ltd.ADS(QNRX)199,486252,434+52,948$965.5K$1.15M0.96%+$185.6K
Tenax Therapeutics, Inc.(TENX)660,000588,000-72,000$9.60M$1.11M0.93%-$8.49M
Zevra Therapeutics, Inc.(ZVRA)258,701100,000-158,701$3.71M$1.10M0.92%-$2.61M
Cabaletta Bio, Inc.(CABA)917,100520,000-397,100$2.85M$998.4K0.83%-$1.85M
Codexis, Inc.(CDXS)109,662676,973+567,311$247.8K$941.0K0.79%+$693.2K
In8bio Inc695,287697,852+2,565$980.4K$928.1K0.77%-$52.2K
Gossamer Bio Inc063,039+63,039$0$747.0K0.62%+$747.0K
Xenon Pharmaceuticals Inc.(XENE)020,000+20,000$0$743.8K0.62%+$743.8K
Azitra, Inc.(AZTR)5,285,4765,227,438-58,038$886.9K$719.3K0.60%-$167.6K
Femasys Inc0326,770+326,770$0$705.8K0.59%+$705.8K
Zentalis Pharmaceuticals, Inc.(ZNTL)161,583254,759+93,176$783.7K$705.7K0.59%-$78.0K
MoonLake ImmunotherapeuticsCL A(MLTX)50,00060,000+10,000$973.5K$702.0K0.59%-$271.5K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)425,00095,000-330,000$3.99M$647.9K0.54%-$3.34M
AEON Biopharma, Inc.CL A(AEON)02,125,748+2,125,748$0$637.7K0.53%+$637.7K
Alumis Inc085,000+85,000$0$628.1K0.52%+$628.1K
CytomX Therapeutics, Inc.(CTMX)205,000220,000+15,000$768.8K$598.4K0.50%-$170.3K
Sintx Technologies, Inc.(SINT)209,205233,936+24,731$332.5K$521.7K0.44%+$189.1K
Zai Lab LimitedADR(ZLAB)018,998+18,998$0$500.4K0.42%+$500.4K
Opus Genetics, Inc.(IRD)100,71898,147-2,571$414.0K$475.0K0.40%+$61.1K
Neumora Therapeutics, Inc.(NMRA)0787,269+787,269$0$469.4K0.39%+$469.4K
Calcimedica Inc0278,680+278,680$0$451.5K0.38%+$451.5K
Pliant Therapeutics, Inc.(PLRX)230,538414,903+184,365$262.8K$448.1K0.37%+$185.3K
OnKure Therapeutics, Inc.CL A(OKUR)130,684162,818+32,134$595.9K$443.7K0.37%-$152.2K
X4 Pharmaceuticals, Inc.(XFOR)224,989150,000-74,989$1.05M$435.0K0.36%-$615.7K
NervGen Pharma Corp.(NGEN)271,678200,000-71,678$559.7K$382.0K0.32%-$177.7K
Eupraxia Pharmaceuticals Inc.(EPRX)43,49140,000-3,491$287.5K$364.0K0.30%+$76.5K
SAB Biotherapeutics, Inc.(SABS)73,27188,108+14,837$285.8K$279.3K0.23%-$6.5K
ImageneBio, Inc.(IMA)057,663+57,663$0$264.1K0.22%+$264.1K
Q32 Bio Inc.(QTTB)031,200+31,200$0$258.0K0.22%+$258.0K
QT Imaging Holdings, Inc.(QTI)100,000100,0000$407.0K$254.5K0.21%-$152.5K
MaxCyte, Inc.(MXCT)751,606224,881-526,725$924.5K$251.9K0.21%-$672.6K
CNS Pharmaceuticals, Inc.(CNSP)41,57339,942-1,631$198.7K$211.7K0.18%+$13.0K
Pulmonx Corporation(LUNG)815,436110,479-704,957$1.06M$211.0K0.18%-$849.1K
EyePoint, Inc.(EYPT)055,000+55,000$0$179.8K0.15%+$179.8K
Ardelyx Inc051,000+51,000$0$174.4K0.15%+$174.4K
Ocular Therapeutix, Inc.(OCUL)020,000+20,000$0$153.4K0.13%+$153.4K
Boundless Bio, Inc.(BOLD)154,59552,547-102,048$386.5K$131.9K0.11%-$254.6K
Climb Bio, Inc.(CLYM)010,000+10,000$0$114.7K0.10%+$114.7K
Kalaris Therapeutics, Inc.(KLRS)30,12233,842+3,720$122.6K$97.8K0.08%-$24.8K
BioAge Labs, Inc.(BIOA)20,00011,948-8,052$490.2K$84.7K0.07%-$405.5K
Connect Biopharma Holdings LimitedSHS(CNTB)364,25449,468-314,786$866.9K$54.4K0.05%-$812.5K
Evaxion A/SADS(EVAX)17,56216,566-996$54.4K$54.3K0.05%-$106
Geron Corporation(GERN)020,000+20,000$0$24.6K0.02%+$24.6K
Adlai Nortye Group Ltd.ADS(ANL)24,2570-24,257$279.0K$0—-$279.0K
Arvinas, Inc.(ARVN)60,0000-60,000$498.6K$0—-$498.6K
BioAtla, Inc.(BCAB)16,4320-16,432$68.0K$0—-$68.0K
CalciMedica, Inc.(CALC)622,4320-622,432$544.9K$0—-$544.9K
Compugen Ltd.(CGEN)31,3870-31,387$67.2K$0—-$67.2K
Crescent Biopharma, Inc.(CBIO)40,0000-40,000$720.0K$0—-$720.0K
Curis, Inc.(CRIS)3,312,1850-3,312,185$1.73M$0—-$1.73M
Helus Pharma Inc(HELP)129,2800-129,280$854.5K$0—-$854.5K
Heron Therapeutics, Inc.(HRTX)490,7870-490,787$209.5K$0—-$209.5K
Humacyte, Inc.(HUMA)231,2990-231,299$180.5K$0—-$180.5K
Nuvectis Pharma, Inc.(NVCT)40,0000-40,000$735.6K$0—-$735.6K
Oruka Therapeutics, Inc.(ORKA)7,5000-7,500$713.8K$0—-$713.8K
Ovid Therapeutics Inc.(OVID)21,3000-21,300$57.3K$0—-$57.3K
Phathom Pharmaceuticals, Inc.(PHAT)85,0100-85,010$922.4K$0—-$922.4K
PMV Pharmaceuticals, Inc.(PMVP)536,0860-536,086$718.4K$0—-$718.4K
Precision Optics Corporation, Inc.(POCI)46,3900-46,390$236.6K$0—-$236.6K
Processa Pharmaceuticals, Inc.(PCSA)55,0000-55,000$105.6K$0—-$105.6K
Radiopharm Theranostics LimitedADS(RADX)51,000,0000-51,000,000$670.5K$0—-$670.5K
Rein Therapeutics Inc.(RNTX)218,0380-218,038$226.8K$0—-$226.8K
Senseonics Holdings, Inc.(SENS)48,6800-48,680$276.5K$0—-$276.5K
Sol-Gel Technologies LtdSHS NEW
SHS NEW
14,4690-14,469$1.07M$0—-$1.07M
Spruce Biosciences Inc28,7950-28,795$1.55M$0—-$1.55M
TELA Bio, Inc.(TELA)2,662,4270-2,662,427$2.00M$0—-$2.00M
Upstream Bio, Inc.(UPB)33,4320-33,432$231.3K$0—-$231.3K
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q3 2026 | TickerTrail